SemBiosys Genetics Inc.  

(Public, TSE:SBS)   Watch this stock  
Find more results for SBS
0.0000
- Close
TSE data delayed by 15 mins - Disclaimer
Currency in
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap 259,200.00
P/E     -
Div/yield     -
EPS -0.09
Shares 51.83M
Beta     -
Inst. own     -

Key stats and ratios

Q1 (Mar '12) 2011
Net profit margin -643952.40% -9781.47%
Operating margin -597171.40% -7519.88%
EBITD margin - -6265.01%
Return on average assets -282.89% -309.40%
Return on average equity - -
Employees 21 -
CDP Score - -

Address

110, 2985 - 23rd Avenue N.E.
CALGARY, AB T1Y 7L3
Canada
+1-403-2505424 (Phone)
+1-403-2503886 (Fax)

Website links

Description

SemBioSys Genetics Inc. (SemBioSys) is a plant-based technology development company that utilizes its renewable, patented, plant seed-based oilbody genetic expression and manufacturing technology platforms to develop, manufacture and commercialize healthy living, animal health and pharmaceutical products. It produces oils and proteins from oil seeds and used to make plant-based general health, functional food, nutraceutical, animal health and pharmaceutical products using its manufacturing systems. In collaboration with its partner, Arcadia BioSciences Inc., the Company used its technology platform to develop a safflower oil containing omega-6 fatty acid gamma linolenic acid (GLA). Its biopharmaceutical pipeline includes Biosimilar Insulin for diabetes and Apo AIMilano for atherosclerotic cardiovascular disease. As of December 31, 2011, SemBioSys owned 30% interest of Tasly-SemBioSys Bio-Pharmaceutical Technology Co. Ltd.

Officers and directors

Richard H. Smith Independent Chairman of the Board
James J. Szarko President, Chief Executive Officer, Director
En Man Ma Chief Financial Officer
Frederick E. Pierce II President - US and International Operations
Hermanus M. Deckers Vice President - Operations and Legal Affairs
Joseph G. Boothe Vice President - Research & Development
Alexander R. Giaquinto Ph.D. Independent Director
Bruce D. Given M.D. Independent Director
Age: 59
Robert John Herdman Independent Director
Age: 61
William H. Smith QC Independent Director